Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Axogen, Inc. (AXGN)
|
Add to portfolio |
|
|
|
| Price: |
$9.98
| | Metrics |
| OS: |
43.0
|
M
| |
-24
|
% ROE
|
| Market cap: |
$429
|
M
| |
-17
|
% ROIC
|
|
Net debt:
|
$11.6
|
M
| |
|
|
|
EV:
|
$441
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($21.5)
|
M
| |
|
|
|
EBIT
|
($24.7)
|
M
| |
|
|
| EPS |
($0.55)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 138.6 | 127.4 | 112.3 | 106.7 | 83.9 | 60.4 | 41.1 | 27.3 |
| Revenue growth | 8.8% | 13.4% | 5.2% | 27.1% | 38.9% | 47.0% | 50.4% | 62.5% |
| Cost of goods sold | 24.1 | 22.9 | 21.6 | 17.3 | 12.9 | 9.3 | 6.5 | 4.8 |
| Gross profit | 114.4 | 104.4 | 90.7 | 89.4 | 71.0 | 51.1 | 34.6 | 22.5 |
| Gross margin | 82.6% | 82.0% | 80.8% | 83.7% | 84.6% | 84.6% | 84.3% | 82.3% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 80.2 | 73.3 | 69.7 | 72.0 | 56.6 | 37.6 | 28.4 | 20.1 |
| Research and development | 27.2 | 24.2 | 17.8 | 17.5 | 11.8 | 6.7 | 4.2 | 3.2 |
| General and administrative | 36.8 | 32.3 | 26.4 | 31.3 | 23.1 | 14.7 | 10.1 | 8.4 |
| EBITA | -29.4 | -25.2 | -23.0 | -31.3 | -20.4 | -7.9 | -8.1 | -9.2 |
| EBITA margin | -21.2% | -19.8% | -20.5% | -29.3% | -24.3% | -13.0% | -19.6% | -33.7% |
| Amortization of intangibles | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| EBIT | -29.7 | -25.4 | -23.2 | -31.4 | -20.5 | -8.0 | -8.1 | -9.3 |
| EBIT margin | -21.4% | -20.0% | -20.6% | -29.4% | -24.4% | -13.2% | -19.8% | -33.9% |
| Pre-tax income | -28.9 | -27.0 | -23.8 | -29.1 | -22.4 | -10.4 | -14.4 | -13.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -28.9 | -27.0 | -23.8 | -29.1 | -22.4 | -10.4 | -14.4 | -13.4 |
| Net margin | -20.9% | -21.2% | -21.2% | -27.3% | -26.7% | -17.3% | -35.1% | -48.9% |
| |
| Diluted EPS | ($0.69) | ($0.65) | ($0.60) | ($0.74) | ($0.60) | ($0.31) | ($0.47) | ($0.51) |
| Shares outstanding (diluted) | 42.1 | 41.2 | 40.0 | 39.2 | 37.1 | 33.3 | 30.7 | 26.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|